Measuring efficacy is a key element in drug development, but involves a great deal of effort. Essential parameters such as the local effect or metabolism are currently not available or only available through invasive animal studies. The "hyperquant" project is developing new methods for the non-invasive measurement and visualization of metabolism, lung function and drug distribution using hyperpolarized MRI, which can also be used for humans. Molecules are magnetically marked so that they can be observed in the body without damaging tissue or having to insert instruments into the body.
In this way, diseases such as cancer or inflammation can be detected at an early stage and the effect of marine extracts on metabolism and tissue can be measured more precisely.